Petros Pharmaceuticals Inc. (NASDAQ: PTPI)
$0.2695
+0.0125 ( +4.86% ) 323.6K
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
Market Data
Open
$0.2695
Previous close
$0.2570
Volume
323.6K
Market cap
$2.68M
Day range
$0.2540 - $0.2820
52 week range
$0.2208 - $2.2700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Nov 21, 2024 |
10-q | Quarterly Reports | 86 | Nov 13, 2024 |
ars | Annual reports | 1 | Oct 25, 2024 |
def | Proxies and info statements | 4 | Oct 25, 2024 |
8-k | 8K-related | 14 | Oct 18, 2024 |
8-k | 8K-related | 15 | Oct 17, 2024 |
pre | Proxies and info statements | 4 | Oct 15, 2024 |
8-k | 8K-related | 13 | Oct 04, 2024 |
8-k | 8K-related | 13 | Sep 19, 2024 |
10-q | Quarterly Reports | 80 | Aug 14, 2024 |